New Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) in Infants and Toddlers with Unmet Clinical Needs after Gene Therapy

Source: Nasdaq GlobeNewswire / 06 Mar 2024 06:30:51   America/Chicago